Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 4843.00 | 4603.75 | 1.0520 | 1.1121 |
| SK-BR-3 | Nilotinib | 10 | uM | 3 | 2500.00 | 2418.67 | 2188.00 | 4603.75 | 0.4753 | -0.1023 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 2500.00 | 2418.67 | 4846.00 | 4603.75 | 1.0526 | 1.1136 |
| SK-BR-3 | Nilotinib | 1 | uM | 3 | 2500.00 | 2418.67 | 4937.00 | 4603.75 | 1.0724 | 1.1563 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4847.00 | 4603.75 | 1.0528 | 1.1140 |
| SK-BR-3 | PLX-4720 | 10 | uM | 3 | 2500.00 | 2418.67 | 4371.00 | 4603.75 | 0.9494 | 0.8913 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 2500.00 | 2418.67 | 1777.00 | 4603.75 | 0.3860 | -0.2825 |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4669.00 | 4603.75 | 1.0142 | 1.0305 | |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 2285.00 | 4603.75 | 0.4963 | -0.0594 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4670.00 | 4603.75 | 1.0144 | 1.0310 |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 2500.00 | 2418.67 | 4178.00 | 4603.75 | 0.9075 | 0.8016 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 2004.00 | 4603.75 | 0.4353 | -0.1833 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 2500.00 | 2418.67 | 1880.00 | 4603.75 | 0.4084 | -0.2376 |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4727.00 | 4603.75 | 1.0268 | 1.0577 | |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4499.00 | 4603.75 | 0.9773 | 0.9510 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5628.00 | 5931.50 | 0.9488 | 0.8121 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5734.00 | 5931.50 | 0.9667 | 0.8767 | |
| SK-BR-3 | Etoposide | 10 | uM | 3 | 5000.00 | 4101.40 | 2653.00 | 5931.50 | 0.4473 | -0.5589 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5856.00 | 5931.50 | 0.9873 | 0.9524 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5875.00 | 5931.50 | 0.9905 | 0.9644 | |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 5000.00 | 4101.40 | 3133.00 | 5931.50 | 0.5282 | -0.3971 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 5716.00 | 5931.50 | 0.9637 | 0.8657 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 6028.00 | 5931.50 | 1.0163 | 1.0616 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 5725.00 | 5931.50 | 0.9652 | 0.8712 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 5000.00 | 4101.40 | 5833.00 | 5931.50 | 0.9834 | 0.9381 |